Delcath Systems, Inc.

DCTH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DCTH stands at 397.4M. In comparison, ARAY has a market cap of 140.1M. Regarding current trading prices, DCTH is priced at $11.41, while ARAY trades at $1.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DCTH currently has a P/E ratio of -25.36, whereas ARAY's P/E ratio is -34.00. In terms of profitability, DCTH's ROE is -0.35%, compared to ARAY's ROE of +0.01%. Regarding short-term risk, DCTH is less volatile compared to ARAY. This indicates potentially lower risk in terms of short-term price fluctuations for DCTH.Check ARAY's competition here

DCTH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DCTH stands at 397.4M. In comparison, COCHW has a market cap of 25.6M. Regarding current trading prices, DCTH is priced at $11.41, while COCHW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DCTH currently has a P/E ratio of -25.36, whereas COCHW's P/E ratio is N/A. In terms of profitability, DCTH's ROE is -0.35%, compared to COCHW's ROE of +1.06%. Regarding short-term risk, DCTH is less volatile compared to COCHW. This indicates potentially lower risk in terms of short-term price fluctuations for DCTH.Check COCHW's competition here